FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362592740> ?p ?o ?g. }

• W4362592740 endingPage "1053" @default.
• W4362592740 startingPage "1053" @default.
• W4362592740 abstract "Abstract Intro: High-Grade Gliomas (HGGs) are the most common and aggressive primary brain tumors in adults and are almost always fatal. Liquid biopsy provides a noninvasive window into the cancer genome and the underlying biology of the tumor. Circulating-tumor DNA (ctDNA) is a versatile analyte for tumor diagnosis, monitoring treatment response, detecting resistance, and tracking tumor evolution. The central hypothesis of our work is that detection of cerebrospinal fluid (CSF) ctDNA correlates with clinically significant events and can be used as a surrogate for tissue biopsy to guide treatment decisions in the clinic. Methods: Our study includes CSF ctDNA samples from 140 recurrent glioma patients at Memorial Sloan Kettering Cancer Center who underwent collection of CSF as part of their clinical evaluation for neurological signs and symptoms. For each patient, glioma subtype and grade were confirmed by a neuropathologist. Overall survival was calculated as the time interval between the date of diagnosis and the date of death. All samples were sequenced using the MSK-IMPACT targeted sequencing assay (468 genes). Allele-specific copy number calls were assessed using the FACETS algorithm. Mutations were classified as drivers based on OncoKB. To evaluate the relationship between CSF ctDNA detection and clinico-pathologic correlates, CSF ctDNA status was determined positive by the presence of at least one somatic mutation and CSF ctDNA status was correlated with clinico-pathologic features. Results: Within this cohort, we found 68 CSF ctDNA positive and 72 CSF negative samples. The most frequently mutated genes were: TERT (58.2%), TP53 (47.8%), IDH1 (20.9%) and EGFR (26.9%). We observed a concordance between contemporaneously sampled tumor and CSF. In a multivariate analysis accounting for established prognostic factors including: % extent of resection at diagnosis; tumor burden at the time of lumbar puncture; and IDH status, we found that CSF ctDNA positivity was negatively correlated with overall survival (HR: 2.52, p &lt;0.0001). Patients with CSF positive samples had an overall survival of 3.35 months vs 11.91 months for those with CSF negative samples (p &lt; 0.0001). Conclusion: ctDNA from CSF depicts a powerful analyte with the potential to alter the standard of care. We have established a robust liquid biopsy program across the neuro-oncology department at MSK, and MSK-IMPACT is now certified by NYS DOH for use on CSF ctDNA enabling routine integration into clinical care. In summary, we are now able to monitor the changing genome along the disease course and have the potential to detect disease occurrence at an earlier time point, however further validation of CSF ctDNA for disease monitoring is needed. Additionally, our data suggests that CSF ctDNA may be used as a prognostic biomarker for survival, but confirmation requires further validation in a prospective study. Citation Format: Subhiksha Nandakumar, Christoph Kreitzer, Charli Ann Hertz, Johnathan Rafailov, Timothy Song, Nicholas D. Socci, A. Rose Brannon, Maria E. Arcila, David B. Solit, Michael F. Berger, Nikolaus Schultz, Ingo K. Mellinghoff, Alexandra M. Miller. Circulating tumor DNA from cerebrospinal fluid (CSF) allows for characterization and monitoring of glioma patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1053." @default.
• W4362592740 created "2023-04-06" @default.
• W4362592740 creator A5000845600 @default.
• W4362592740 creator A5004474117 @default.
• W4362592740 creator A5009048952 @default.
• W4362592740 creator A5018660200 @default.
• W4362592740 creator A5020324479 @default.
• W4362592740 creator A5033125884 @default.
• W4362592740 creator A5037092952 @default.
• W4362592740 creator A5046654923 @default.
• W4362592740 creator A5053263729 @default.
• W4362592740 creator A5064055667 @default.
• W4362592740 creator A5074486474 @default.
• W4362592740 creator A5080705644 @default.
• W4362592740 creator A5090667008 @default.
• W4362592740 date "2023-04-04" @default.
• W4362592740 modified "2023-10-16" @default.
• W4362592740 title "Abstract 1053: Circulating tumor DNA from cerebrospinal fluid (CSF) allows for characterization and monitoring of glioma patients" @default.
• W4362592740 doi "https://doi.org/10.1158/1538-7445.am2023-1053" @default.
• W4362592740 hasPublicationYear "2023" @default.
• W4362592740 type Work @default.
• W4362592740 citedByCount "0" @default.
• W4362592740 crossrefType "journal-article" @default.
• W4362592740 hasAuthorship W4362592740A5000845600 @default.
• W4362592740 hasAuthorship W4362592740A5004474117 @default.
• W4362592740 hasAuthorship W4362592740A5009048952 @default.
• W4362592740 hasAuthorship W4362592740A5018660200 @default.
• W4362592740 hasAuthorship W4362592740A5020324479 @default.
• W4362592740 hasAuthorship W4362592740A5033125884 @default.
• W4362592740 hasAuthorship W4362592740A5037092952 @default.
• W4362592740 hasAuthorship W4362592740A5046654923 @default.
• W4362592740 hasAuthorship W4362592740A5053263729 @default.
• W4362592740 hasAuthorship W4362592740A5064055667 @default.
• W4362592740 hasAuthorship W4362592740A5074486474 @default.
• W4362592740 hasAuthorship W4362592740A5080705644 @default.
• W4362592740 hasAuthorship W4362592740A5090667008 @default.
• W4362592740 hasConcept C104317684 @default.
• W4362592740 hasConcept C121608353 @default.
• W4362592740 hasConcept C126322002 @default.
• W4362592740 hasConcept C127848430 @default.
• W4362592740 hasConcept C141341695 @default.
• W4362592740 hasConcept C142724271 @default.
• W4362592740 hasConcept C143998085 @default.
• W4362592740 hasConcept C2775934546 @default.
• W4362592740 hasConcept C2778227246 @default.
• W4362592740 hasConcept C2779130545 @default.
• W4362592740 hasConcept C2779529041 @default.
• W4362592740 hasConcept C2779651940 @default.
• W4362592740 hasConcept C2781335228 @default.
• W4362592740 hasConcept C501734568 @default.
• W4362592740 hasConcept C502942594 @default.
• W4362592740 hasConcept C54355233 @default.
• W4362592740 hasConcept C71924100 @default.
• W4362592740 hasConcept C86803240 @default.
• W4362592740 hasConceptScore W4362592740C104317684 @default.
• W4362592740 hasConceptScore W4362592740C121608353 @default.
• W4362592740 hasConceptScore W4362592740C126322002 @default.
• W4362592740 hasConceptScore W4362592740C127848430 @default.
• W4362592740 hasConceptScore W4362592740C141341695 @default.
• W4362592740 hasConceptScore W4362592740C142724271 @default.
• W4362592740 hasConceptScore W4362592740C143998085 @default.
• W4362592740 hasConceptScore W4362592740C2775934546 @default.
• W4362592740 hasConceptScore W4362592740C2778227246 @default.
• W4362592740 hasConceptScore W4362592740C2779130545 @default.
• W4362592740 hasConceptScore W4362592740C2779529041 @default.
• W4362592740 hasConceptScore W4362592740C2779651940 @default.
• W4362592740 hasConceptScore W4362592740C2781335228 @default.
• W4362592740 hasConceptScore W4362592740C501734568 @default.
• W4362592740 hasConceptScore W4362592740C502942594 @default.
• W4362592740 hasConceptScore W4362592740C54355233 @default.
• W4362592740 hasConceptScore W4362592740C71924100 @default.
• W4362592740 hasConceptScore W4362592740C86803240 @default.
• W4362592740 hasIssue "7_Supplement" @default.
• W4362592740 hasLocation W43625927401 @default.
• W4362592740 hasOpenAccess W4362592740 @default.
• W4362592740 hasPrimaryLocation W43625927401 @default.
• W4362592740 hasRelatedWork W2800183750 @default.
• W4362592740 hasRelatedWork W3030677138 @default.
• W4362592740 hasRelatedWork W3154638193 @default.
• W4362592740 hasRelatedWork W3170193548 @default.
• W4362592740 hasRelatedWork W3202808527 @default.
• W4362592740 hasRelatedWork W4286298705 @default.
• W4362592740 hasRelatedWork W4308917339 @default.
• W4362592740 hasRelatedWork W4362592740 @default.
• W4362592740 hasRelatedWork W4384388153 @default.
• W4362592740 hasRelatedWork W3107561318 @default.
• W4362592740 hasVolume "83" @default.
• W4362592740 isParatext "false" @default.
• W4362592740 isRetracted "false" @default.
• W4362592740 workType "article" @default.